Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Bruce L. Davidson, MD MPH, Philip S. Wells, MD FRCPC, MSc, Martin H. Prins, MD PhD, Jan Beyer-Westendorf, MD, Anthonie WA. Lensing, MD PhD, Lloyd Haskell, MD, Bennett Levitan, MD PhD, François Laliberté, Veronica Ashton, MPH, Yongling Xiao, PhD, Dominique Lejeune, Concetta Crivera, Patrick Lefebvre, MA, Qi Zhao, MPH, Zhong Yuan, MD PhD, Jeff Schein, Paolo Prandoni, MD PhD

Blood (2017) 130 (Supplement 1): 218.

https://doi.org/10.1182/blood.V130.Suppl_1.218.218

Published: 2017

Journal Articles

Extended Non-Vitamin K Antagonist Oral Anticoagulation Therapy for Prevention of Recurrent Venous Thromboembolism. a Review of Phase III and Phase IV Studies

Franco Piovella, MD, Diana I Iosub, MD

Blood (2016) 128 (22): 5011.

https://doi.org/10.1182/blood.V128.22.5011.5011

Published: 2016

Journal Articles

Assessment of Multiple Myeloma Patient Preferences on Treatment Choices: An International Discrete Choice Study

Xavier Leleu, Maria-Victoria Mateos, Michel Delforge, Philip Lewis, Thomas Schindler, Craig Gibson, Min Yang, Katja C. Weisel

Blood (2015) 126 (23): 2086.

https://doi.org/10.1182/blood.V126.23.2086.2086

Published: 2015

Journal Articles

Patients Are Willing to Trade off Efficacy, Safety, and Administration Attributes of Chronic Idiopathic Purpura (ITP) Therapy: Results from a Large North American Discrete Choice Study

Kelly M Grotzinger, F. Reed Johnson, A. Brett Hauber, Semra Özdemir, Mohan V Bala

Blood (2008) 112 (11): 669.

https://doi.org/10.1182/blood.V112.11.669.669

Published: 2008

Journal Articles

Heparin-Induced Thrombocytopenia Antibodies Do Not Predict Adverse Outcomes in End-Stage Renal Disease Patients on Dialysis.

Lars M. Asmis, MD, Jodi B. Segal, MD, MPH, Laura C. Plantinga, MPH, Nancy E. Fink, MPH, Jonathan S. Kerman, Thomas S. Kickler, MD, Josef Coresh, MD, Lawrence B. Gardner, MD

Blood (2004) 104 (11): 3517.

https://doi.org/10.1182/blood.V104.11.3517.3517

Published: 2004

NARROW

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Extended Non-Vitamin K Antagonist Oral Anticoagulation Therapy for Prevention of Recurrent Venous Thromboembolism. a Review of Phase III and Phase IV Studies

Assessment of Multiple Myeloma Patient Preferences on Treatment Choices: An International Discrete Choice Study

Patients Are Willing to Trade off Efficacy, Safety, and Administration Attributes of Chronic Idiopathic Purpura (ITP) Therapy: Results from a Large North American Discrete Choice Study

Heparin-Induced Thrombocytopenia Antibodies Do Not Predict Adverse Outcomes in End-Stage Renal Disease Patients on Dialysis.

Email alerts

ASH Publications

American Society of Hematology

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Extended Non-Vitamin K Antagonist Oral Anticoagulation Therapy for Prevention of Recurrent Venous Thromboembolism. a Review of Phase III and Phase IV Studies

Assessment of Multiple Myeloma Patient Preferences on Treatment Choices: An International Discrete Choice Study

Patients Are Willing to Trade off Efficacy, Safety, and Administration Attributes of Chronic Idiopathic Purpura (ITP) Therapy: Results from a Large North American Discrete Choice Study

Heparin-Induced Thrombocytopenia Antibodies Do Not Predict Adverse Outcomes in End-Stage Renal Disease Patients on Dialysis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only